{"id":19570,"date":"2025-08-18T12:45:02","date_gmt":"2025-08-18T12:45:02","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=19570"},"modified":"2025-08-18T12:45:02","modified_gmt":"2025-08-18T12:45:02","slug":"eisais-insomnia-drug-dayvigo-approved-for-use-in-china","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/eisais-insomnia-drug-dayvigo-approved-for-use-in-china\/","title":{"rendered":"\u30a8\u30fc\u30b6\u30a4\u306e\u4e0d\u7720\u75c7\u6cbb\u7642\u85ac\u300cDAYVIGO\u300d\u3001\u4e2d\u56fd\u3067\u627f\u8a8d\u3092\u53d6\u5f97"},"content":{"rendered":"<p><a href=\"https:\/\/www.eisai.com\/\">\u30a8\u30fc\u30b6\u30a4\u682a\u5f0f\u4f1a\u793e<\/a>\u4e2d\u56fdDAYVIGO\u00ae\uff08lemborexant\uff09\u304c\u4e2d\u56fd\u3067\u627f\u8a8d\u3055\u308c\u3001\"\u8fbe\u536b\u53ef\u00ae\"\u3068\u3057\u3066\u8ca9\u58f2\u3055\u308c\u307e\u3059\u30022025\u5e74\u5ea6\u7b2c2\u56db\u534a\u671f\u306b\u767a\u58f2\u4e88\u5b9a\u3002\u672c\u5264\u306f\u3001\u5165\u7720\u969c\u5bb3\u3084\u7761\u7720\u7dad\u6301\u969c\u5bb3\u306e\u3042\u308b\u6210\u4eba\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>DAYVIGO\u306f\u4e8c\u91cd\u30aa\u30ec\u30ad\u30b7\u30f3\u53d7\u5bb9\u4f53\u62ee\u6297\u85ac\u3067\u3059\u3002\u30aa\u30ec\u30ad\u30b7\u30f3\u53d7\u5bb9\u4f53OX1R\u3068OX2R\u306b\u7d50\u5408\u3059\u308b\u3053\u3068\u306b\u3088\u308a\u3001\u8133\u306e\u7761\u7720\u899a\u9192\u30b7\u30b9\u30c6\u30e0\u3092\u30bf\u30fc\u30b2\u30c3\u30c8\u306b\u3057\u307e\u3059\u3002OX2R\u306b\u306f\u3088\u308a\u5f37\u304f\u4f5c\u7528\u3057\u307e\u3059\u3002\u3053\u306e\u30e1\u30ab\u30cb\u30ba\u30e0\u306f\u3001\u5165\u7720\u3068\u7761\u7720\u7dad\u6301\u3092\u52a9\u3051\u307e\u3059\u3002\u3053\u308c\u306f\u3001\u30ec\u30e0\u7761\u7720\u3068\u30ce\u30f3\u30ec\u30e0\u7761\u7720\u306e\u4e21\u65b9\u306e\u6b32\u6c42\u3092\u6291\u3048\u308b\u3053\u3068\u306b\u3088\u3063\u3066\u884c\u308f\u308c\u307e\u3059\u3002<\/p>\n<p>\u4eca\u56de\u306e\u627f\u8a8d\u306f\u3001\u7d042,000\u4eba\u306e\u6210\u4eba\u3092\u5bfe\u8c61\u3068\u3057\u305f\u56fd\u969b\u5171\u540c\u7b2c3\u76f8\u8a66\u9a13\uff08SUNRISE 1\u304a\u3088\u30732\uff09\u306e\u7d50\u679c\u5f97\u3089\u308c\u305f\u3082\u306e\u3067\u3059\u3002\u307e\u305f\u3001\u4e2d\u56fd\u306b\u7279\u5316\u3057\u305f\u30d5\u30a7\u30fc\u30ba3\u8a66\u9a13\u3082\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u3002\u305d\u306e\u7d50\u679c\u3001\u4e0d\u7720\u75c7\u72b6\u306b\u5bfe\u3059\u308b\u672c\u5264\u306e\u6709\u52b9\u6027\u304c\u5b9f\u8a3c\u3055\u308c\u307e\u3057\u305f\u3002<\/p>\n<h4>\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a class=\"p-url\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/lantern-pharma-completes-lp-300-lung-cancer-trial-signup\/\" rel=\"bookmark\">\u30e9\u30f3\u30bf\u30f3\u30fb\u30d5\u30a1\u30fc\u30de\u3001LP-300 \u80ba\u304c\u3093\u81e8\u5e8a\u8a66\u9a13\u306e\u5951\u7d04\u3092\u5b8c\u4e86<\/a><\/h4>\n<p>\u4e2d\u56fd\u3067\u306f\u4e0d\u7720\u75c7\u304c\u4e00\u822c\u7684\u3067\u3059\u30022025\u5e74\u4e2d\u56fd\u7761\u7720\u5065\u5eb7\u8abf\u67fb\u306b\u3088\u308b\u3068\u3001\u6210\u4eba\u306e\u7d04\u534a\u6570\u304c\u4e0d\u7720\u75c7\u306b\u60a9\u3093\u3067\u3044\u307e\u3059\u3002\u5973\u6027\u3068\u9ad8\u9f62\u8005\u304c\u3088\u308a\u5f71\u97ff\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002DAYVIGO\u306f\u73fe\u5728\u3001\u65e5\u672c\u3001\u7c73\u56fd\u3001\u30ab\u30ca\u30c0\u306a\u306922\u30ab\u56fd\u3067\u627f\u8a8d\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4e2d\u56fd\u3067\u306e\u767a\u58f2\u306f\u3001\u7761\u7720\u969c\u5bb3\u306e\u65b0\u305f\u306a\u6cbb\u7642\u306b\u5bfe\u3059\u308b\u30cb\u30fc\u30ba\u306e\u9ad8\u307e\u308a\u3092\u793a\u3059\u3082\u306e\u3067\u3059\u3002<\/p>","protected":false},"excerpt":{"rendered":"<p>Eisai Co., Ltd. DAYVIGO\u00ae (lemborexant) has been approved in China, where it\u2019s sold as \u201c\u8fbe\u536b\u53ef\u00ae.\u201d The drug will likely launch in the second quarter of fiscal year 2025. It\u2019s for adults who have trouble falling asleep or staying asleep. DAYVIGO is a dual orexin receptor antagonist. It targets the brain&#8217;s sleep-wake system by binding to orexin receptors OX1R and OX2R. It has a stronger effect on OX2R. This mechanism helps you fall asleep and stay asleep. It does this by reducing the drive for both REM and non-REM sleep. The approval comes after global Phase 3 trials (SUNRISE 1 and 2) with about 2,000 adults. It also includes a Phase [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":19577,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[89,207,237,182,1838,206],"tags":[7170,7172,1715,7171,424],"ppma_author":[572],"class_list":{"0":"post-19570","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health-tech","8":"category-international","9":"category-news","10":"category-pharma","11":"category-quick-reads","12":"category-regional","13":"tag-anti-insomnia-drug","14":"tag-dayvigo","15":"tag-eisai","16":"tag-lemborexant","17":"tag-pharma"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>China Grants Approval to Eisai\u2019s Anti-Insomnia Drug DAYVIGO<\/title>\n<meta name=\"description\" content=\"Eisai\u2019s DAYVIGO\u00ae (lemborexant) approved in China for adults with insomnia, expected to launch in Q2 FY2025.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/eisais-insomnia-drug-dayvigo-approved-for-use-in-china\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China Grants Approval to Eisai\u2019s Anti-Insomnia Drug DAYVIGO\" \/>\n<meta property=\"og:description\" content=\"Eisai\u2019s DAYVIGO\u00ae (lemborexant) approved in China for adults with insomnia, expected to launch in Q2 FY2025.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/eisais-insomnia-drug-dayvigo-approved-for-use-in-china\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-18T12:45:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/08\/Eisais-Insomnia-drug-DAYVIGO-approved-for-Use-in-China-01.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"2500\" \/>\n\t<meta property=\"og:image:height\" content=\"1667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30a8\u30fc\u30b6\u30a4\u306e\u6297\u4e0d\u7720\u75c7\u85ac\u300cDAYVIGO\u300d\u304c\u4e2d\u56fd\u3067\u627f\u8a8d\u53d6\u5f97","description":"\u30a8\u30fc\u30b6\u30a4\u306eDAYVIGO\u00ae\uff08\u4e00\u822c\u540d\uff1alemborexant\uff09\u3001\u4e2d\u56fd\u3067\u6210\u4eba\u306e\u4e0d\u7720\u75c7\u306e\u52b9\u80fd\u30fb\u52b9\u679c\u3067\u627f\u8a8d\u53d6\u5f97\u30012025\u5e74\u5ea6\u7b2c2\u56db\u534a\u671f\u306b\u767a\u58f2\u4e88\u5b9a.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/eisais-insomnia-drug-dayvigo-approved-for-use-in-china\/","og_locale":"ja_JP","og_type":"article","og_title":"China Grants Approval to Eisai\u2019s Anti-Insomnia Drug DAYVIGO","og_description":"Eisai\u2019s DAYVIGO\u00ae (lemborexant) approved in China for adults with insomnia, expected to launch in Q2 FY2025.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/eisais-insomnia-drug-dayvigo-approved-for-use-in-china\/","og_site_name":"itbusinesstoday","article_published_time":"2025-08-18T12:45:02+00:00","og_image":[{"width":2500,"height":1667,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/08\/Eisais-Insomnia-drug-DAYVIGO-approved-for-Use-in-China-01.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisais-insomnia-drug-dayvigo-approved-for-use-in-china\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisais-insomnia-drug-dayvigo-approved-for-use-in-china\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"Eisai\u2019s Insomnia drug DAYVIGO approved for Use in China","datePublished":"2025-08-18T12:45:02+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisais-insomnia-drug-dayvigo-approved-for-use-in-china\/"},"wordCount":198,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisais-insomnia-drug-dayvigo-approved-for-use-in-china\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/08\/Eisais-Insomnia-drug-DAYVIGO-approved-for-Use-in-China-01.webp","keywords":["Anti-Insomnia drug","DAYVIGO","Eisai","lemborexant","Pharma"],"articleSection":["Health Tech","International","News","Pharma","Quick Reads","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisais-insomnia-drug-dayvigo-approved-for-use-in-china\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisais-insomnia-drug-dayvigo-approved-for-use-in-china\/","name":"\u30a8\u30fc\u30b6\u30a4\u306e\u6297\u4e0d\u7720\u75c7\u85ac\u300cDAYVIGO\u300d\u304c\u4e2d\u56fd\u3067\u627f\u8a8d\u53d6\u5f97","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisais-insomnia-drug-dayvigo-approved-for-use-in-china\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisais-insomnia-drug-dayvigo-approved-for-use-in-china\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/08\/Eisais-Insomnia-drug-DAYVIGO-approved-for-Use-in-China-01.webp","datePublished":"2025-08-18T12:45:02+00:00","description":"\u30a8\u30fc\u30b6\u30a4\u306eDAYVIGO\u00ae\uff08\u4e00\u822c\u540d\uff1alemborexant\uff09\u3001\u4e2d\u56fd\u3067\u6210\u4eba\u306e\u4e0d\u7720\u75c7\u306e\u52b9\u80fd\u30fb\u52b9\u679c\u3067\u627f\u8a8d\u53d6\u5f97\u30012025\u5e74\u5ea6\u7b2c2\u56db\u534a\u671f\u306b\u767a\u58f2\u4e88\u5b9a.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisais-insomnia-drug-dayvigo-approved-for-use-in-china\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisais-insomnia-drug-dayvigo-approved-for-use-in-china\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisais-insomnia-drug-dayvigo-approved-for-use-in-china\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/08\/Eisais-Insomnia-drug-DAYVIGO-approved-for-Use-in-China-01.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/08\/Eisais-Insomnia-drug-DAYVIGO-approved-for-Use-in-China-01.webp","width":2500,"height":1667,"caption":"Eisai"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/eisais-insomnia-drug-dayvigo-approved-for-use-in-china\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Eisai\u2019s Insomnia drug DAYVIGO approved for Use in China"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/19570","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=19570"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/19570\/revisions"}],"predecessor-version":[{"id":19571,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/19570\/revisions\/19571"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/19577"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=19570"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=19570"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=19570"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=19570"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}